XML 43 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Merger (Details) - USD ($)
$ in Thousands
 1 Months Ended 9 Months Ended 12 Months Ended
Nov. 13, 2024
Aug. 22, 2024
Dec. 11, 2023
Feb. 28, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Merger [Line Items]              
Converted into shares 0.068            
Additional shares         483,333    
Shares of common shares       5,000      
Aggregate purchase price (in Dollars)   $ 5,000          
Repay promissory note (in Dollars)         $ 553  
Cash (in Dollars)         $ 328 1 $ 2,850
Incentive shares         33,333    
Forfeited number of shares     32,215        
Proceeds from financing (in Dollars)         $ 553  
Accrued expenses (in Dollars)         325   325
Warrant [Member]              
Merger [Line Items]              
Number of shares of warrant 0.068            
Promissory Note Agreement [Member]              
Merger [Line Items]              
Repay promissory note (in Dollars)         4,225    
Cash (in Dollars)         $ 2,000    
PIPE Shares [Member]              
Merger [Line Items]              
Shares of common shares         112,247    
Aggregate purchase price (in Dollars)         $ 6,225    
Abpro Bio International, Inc. [Member]              
Merger [Line Items]              
Shares of common shares         20,749    
ABI [Member]              
Merger [Line Items]              
Shares of common shares     32,778   41,498    
Sponsor [Member]              
Merger [Line Items]              
Shares of common shares     32,778        
Repayment of amount (in Dollars)         $ 2,000    
ACAB [Member]              
Merger [Line Items]              
Shares of common shares     6,667        
Remaining shares issued         35,000    
Liabilities (in Dollars)         $ 5,300   5,800
Accrued expenses (in Dollars)         900   1,000
Tax payable (in Dollars)         $ 4,400   4,400
Income tax payable (in Dollars)             $ 400
PIPE Financing [Member]              
Merger [Line Items]              
Shares of common shares         36,095    
Proceeds from financing (in Dollars)         $ 5,700    
Transaction costs (in Dollars)         2,100    
Issuance costs (in Dollars)         $ 900    
Investment Advisor [Member]              
Merger [Line Items]              
Shares of common shares         1,095    
Legacy Abpro [Member]              
Merger [Line Items]              
Liabilities net (in Dollars)         $ 6,600    
Preferred Stock [Member]              
Merger [Line Items]              
Converted into shares 0.068            
Series A Common Stock [Member]              
Merger [Line Items]              
Converted shares of common stock         6,744,550    
Shares of common shares         11,043    
Series B Common Stock [Member]              
Merger [Line Items]              
Converted shares of common stock         1    
Common Stock [Member] | Celltrion, Inc. [Member]              
Merger [Line Items]              
Shares of common shares   16,667          
Common Stock [Member] | Sponsor [Member]              
Merger [Line Items]              
Shares of common shares         20,020    
Private Placement [Member]              
Merger [Line Items]              
Total consideration (in Dollars)         $ 11,225